checkAd
    Startseite > Aktien > Enzolytics > Nachrichten
    Enzolytics Aktie
    0,0053
     
    USD
    +7,29 %
    +0,0004 USD
    Letzter Kurs 02:10:00 Nasdaq OTC
    ISIN: US2941121079 · WKN: A2QMQC · SYM: ENZC · USA

    Neueste Nachrichten

    Enzolytics Inc. Announces Dismissal of The Dimitar Savov Lawsuit in Nevada
    23.04.24 · Accesswire · Enzolytics
    Update on Formulation of New Business Strategy
    12.04.24 · Accesswire · Enzolytics
    Enzolytics, Inc. Files Amended December 31, 2022 OTC Report with Audited Financials and Unaudited September 30, 2023 Quarterly Disclosure
    20.11.23 · Accesswire · Enzolytics
    Enzolytics Announces the Signing of the Business Combination Agreement with Sagaliam Acquisition Corp (SAGA)
    18.09.23 · Accesswire · Enzolytics
    Patient Population for the Clinical Trials of ITV-1 has been Established by the European Medicines Agency ("EMA")
    06.09.23 · Accesswire · Enzolytics
    Biogenysis, Inc. Announces Partnering with Khalpey AI Lab and Contenta, Ltd. to Incorporate AI in Microbiome Analysis to Identify Biomarkers for Use in Accurately Predicting Alzheimer's Disease Onset and Prevention.
    05.09.23 · Accesswire · Enzolytics
    Biogenysis’ International Patent Application, Covering Its Anti-SARS-CoV-2 Monoclonal Antibodies, Advances to Prosecution in Europe and as a U.S. National Stage Application.
    24.08.23 · Accesswire · Enzolytics
    Virogentics, Inc. Receives Permit for Export to Africa of the ITV-1 Immunotherapy Solidifying the Scheduled Administration of the Treatment
    08.08.23 · Accesswire · Enzolytics
    Virogentics, Inc. Provides Update on African Project, European Medicine Agency Application and Clinical Trials for Application for Type 2 Diabetes
    04.08.23 · Accesswire · Enzolytics
    CORRECTION FROM SOURCE: Virogentics Announces Approval of Final Protocol from the Dept for HIV and AIDS, Ministry of Health of the DRC
    24.07.23 · Accesswire · Enzolytics
    Virogentics, Inc to Introduce a Dietary Supplement Offers Additional Information on ITV-1 and Diabetic Clinical Trials
    24.07.23 · Accesswire · Enzolytics
    Biogenysis Inc. Announces a Collaboration with Khalpey AI Lab in using Artificial Intelligence (AI) for Unveiling Potential Biomarkers and Predicting the Onset or Prevention of Alzheimer's Disease.
    21.07.23 · Accesswire · Enzolytics